Centers for Disease Control and Prevention: National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta: Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, 2011.
2.
OgdenCL, CarrollMD, KitBK, FlegalKM: Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA, 2014; 311:806–814.
3.
SmythS, HeronA: Diabetes and obesity: the twin epidemics. Nat Med, 2006; 12:75–80.
4.
PoriesWJ, CaroJF, FlickingerEG, et al.: The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville gastric bypass. Ann Surg, 1987; 206:316–323.
5.
NoriaSF, GrantcharovT: Biological effects of bariatric surgery on obesity-related comorbidities. Can J Surg, 2013; 56:47–57.
6.
BuchwaldH, OienDM: Metabolic/bariatric surgery worldwide 2011. Obes Surg, 2013; 23:427–436.
7.
GloyVL, BrielM, BhattDL, et al.: Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ, 2013; 347:f5934.
8.
ColquittJL, PicotJ, LovemanE, CleggAJ: Surgery for obesity. Cochrane Database Syst Rev, 2009;(2):CD003641.
9.
BradleyD, MagkosF, KleinS: Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology, 2012; 143:897–912.
10.
Gastrointestinal surgery for severe obesity. Consens Statement, 1991; 9:1–20.
11.
ParikhM, IssaR, VieiraD, et al.: Role of bariatric surgery as treatment for type 2 diabetes in patients who do not meet current NIH6 criteria: a systematic review and meta-analysis. J Am Coll Surg, 2013; 217:527–532.
12.
ChangSH, StollCR, SongJ, et al.: The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg, 2014; 149:275–287.
13.
TerranovaL, BusettoL, VestriA, et al.: Bariatric surgery: cost-effectiveness and budget impact. Obes Surg, 2012; 22:646–53.
14.
FalkenY, HellstromPM, HolstJJ, et al.: Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. J Clin Endocrinol Metab, 2011; 96:2227–2235.
15.
LaferrereB, TeixeiraJ, McGintyJ, et al.: Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab, 2008; 93:2479–2485.
16.
SchauerPR, BhattDL, KirwanJP, et al.: Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med, 2014; 370:2002–2013.
17.
ChikunguwoSM, WolfeLG, DodsonP, et al.: Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis, 2010; 6:254–259.
18.
CarlssonLM, PeltonenM, AhlinS, et al.: Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med, 2012; 367:695–704.
19.
American Diabetes Association: Executive summary: Standards of medical care in diabetes—2012. Diabetes Care, 2012; 35(Suppl 1):S4–S10.
